Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2GHo1sJ
via IFTTT